報價延遲最少15分鐘:2025/09/18 16:57 EDT
盤後時段
|
||||
|
0.393 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.95/-0.56
|
|
企業價值
35.54M
|
| 資產負債 |
|
每股賬面淨值
0.28
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
6.77M
|
|
每股收益
1.89
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/09/18 16:57 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services. |
